Screening for Fabry Disease in a Pediatric Population at Risk
NCT02152189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1422
Last updated 2017-12-13
Summary
The purpose of this study is to assess the frequency of Fabry disease in children with chronic abdominal pain or chronic pain in the extremities
Conditions
- Chronic Pain in the Extremities
- Chronic Abdominal Pain
- Fabry Disease
Interventions
- OTHER
-
Screening for Fabry disease
Sponsors & Collaborators
-
University Hospital Heidelberg
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2017-05-31
- Completion
- 2017-11-30
Countries
- Germany
Study Locations
More Related Trials
-
Sophisticated Assessment of Disease Burden in Patients With Fabry Disease
NCT01210196 ·Status: COMPLETED
-
Studying Lipids as Potential Biomarkers in Patients With Fabry Disease
NCT05046379 ·Status: COMPLETED
-
A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.
NCT00233870 ·Status: COMPLETED
-
Data Collection in Women With Fabry Disease
NCT00030134 ·Status: COMPLETED
-
Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment
NCT07277361 ·Status: RECRUITING
-
A Study of Fabrazyme in Pediatric Patients With Fabry Disease
NCT00074958 ·Status: COMPLETED ·Phase: PHASE2
-
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
NCT04002531 ·Status: COMPLETED ·Phase: NA
-
Study of the Spermatic Characteristics of Patients With Fabry Disease
NCT04073888 ·Status: COMPLETED ·Phase: NA
-
Registry of Fabry Disease - A Multicenter Observational Study
NCT00055016 ·Status: COMPLETED
-
Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)
NCT05671770 ·Status: COMPLETED
-
Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients
NCT04552691 ·Status: APPROVED_FOR_MARKETING
-
Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
NCT00487630 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
NCT07187440 ·Status: RECRUITING
-
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742 ·Status: RECRUITING
-
Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
NCT02194985 ·Status: COMPLETED ·Phase: PHASE3
-
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
NCT06858397 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Characterisation of Heart Involvement in Fabry Disease With T1 Mapping
NCT04708301 ·Status: COMPLETED
-
A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190
NCT04455230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
NCT00074971 ·Status: COMPLETED ·Phase: PHASE3
-
Facioscapulohumeral Dystrophy in Children
NCT02625662 ·Status: COMPLETED
-
Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
NCT00106912 ·Status: COMPLETED
-
Global Burden and Treatment Trajectiories in Italian Patients With Fabry Disease
NCT04916977 ·Status: COMPLETED
-
MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
NCT03683966 ·Status: UNKNOWN
-
A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.
NCT04281537 ·Status: COMPLETED
-
Fabry's Disease and Pregnancy (PREFAB)
NCT02582294 ·Status: TERMINATED